Atea Pharmaceuticals (AVIR) Change in Account Payables (2019 - 2026)
Atea Pharmaceuticals (AVIR) posted quarterly Change in Account Payables of -$3.5 million for Q1 2026, down 219.46% year-over-year from $2.9 million in Q1 2025, and down 137.1% quarter-over-quarter from $9.4 million in Q4 2025.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Change in Account Payables (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' Change in Account Payables history runs 8 years deep, the most recent figure standing at -$3.5 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 219.46% year-over-year to -$3.5 million; the TTM figure through Mar 2026 stood at $2.1 million (up 114.97% YoY), while the FY2025 annual figure was $8.5 million, up 4019.9% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$3.5 million, down from $9.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $16.9 million in Q1 2024, with the low at -$15.7 million in Q2 2024.
- The 5-year median for Change in Account Payables is $315000.0 (2024), against an average of $288941.2.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 1012.21% in 2024, then tumbled 1791.75% in 2025.
- Atea Pharmaceuticals' Change in Account Payables stood at $1.4 million in 2022, then soared by 169.16% to $3.9 million in 2023, then plunged by 134.4% to -$1.3 million in 2024, then soared by 810.63% to $9.4 million in 2025, then sank by 137.1% to -$3.5 million in 2026.
- Business Quant data shows AVIR's Change in Account Payables at -$3.5 million in Q1 2026, $9.4 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Atea Pharmaceuticals | 468.30 Mn | 468.30 Mn | - | 612,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 612,000.00 |
| Mar 31, 2026 | -3.50 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | -1.33 Mn |
| Sep 30, 2024 | 315,000.00 |
| Jun 30, 2024 | -15.67 Mn |
| Mar 31, 2024 | 16.89 Mn |
| Dec 31, 2023 | 3.86 Mn |
| Sep 30, 2023 | -3.57 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Mar 31, 2023 | -1.85 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | -12.77 Mn |
| Jun 30, 2022 | 10.23 Mn |
| Mar 31, 2022 | -877,000.00 |
| Dec 31, 2021 | -17.66 Mn |
| Sep 30, 2021 | 11.49 Mn |